Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2005-6-14
pubmed:abstractText
Rheumatoid arthritis (RA) is a systemic autoimmune disease of unknown etiology. We studied the diagnostic performances of anti-cyclic citrullinated peptides antibody (anti-CCP) assay and recombinant anti-citrullinated filaggrin antibody (AFA) assay by enzyme linked immunosorbent assay (ELISA) in patients with RA in Korea. Diagnostic performances of the anti-CCP assay and AFA assay were compared with that of rheumatoid factor (RF) latex fixation test. RF, anti-CCP, and AFA assays were performed in 324 RA patients, 251 control patients, and 286 healthy subjects. The optimal cut off values of each assay were determined at the maximal point of area under the curve by receiver-operator characteristics (ROC) curve. Sensitivity (72.8%) and specificity (92.0%) of anti-CCP were better than those of AFA (70.3%, 70.5%), respectively. The diagnostic performance of RF showed a sensitivity of 80.6% and a specificity of 78.5%. Anti-CCP and AFA showed positivity in 23.8% and 17.3% of seronegative RA patients, respectively. In conclusion, we consider that anti-CCP could be very useful serological assay for the diagnosis of RA, because anti-CCP revealed higher diagnostic specificity than RF and AFA at the optimal cut off values and could be performed by easy, convenient ELISA method.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/15953872-10229141, http://linkedlifedata.com/resource/pubmed/commentcorrection/15953872-10343539, http://linkedlifedata.com/resource/pubmed/commentcorrection/15953872-10643712, http://linkedlifedata.com/resource/pubmed/commentcorrection/15953872-10943873, http://linkedlifedata.com/resource/pubmed/commentcorrection/15953872-11324923, http://linkedlifedata.com/resource/pubmed/commentcorrection/15953872-11324930, http://linkedlifedata.com/resource/pubmed/commentcorrection/15953872-11502616, http://linkedlifedata.com/resource/pubmed/commentcorrection/15953872-14178016, http://linkedlifedata.com/resource/pubmed/commentcorrection/15953872-3358796, http://linkedlifedata.com/resource/pubmed/commentcorrection/15953872-6195345, http://linkedlifedata.com/resource/pubmed/commentcorrection/15953872-7504913, http://linkedlifedata.com/resource/pubmed/commentcorrection/15953872-7539459, http://linkedlifedata.com/resource/pubmed/commentcorrection/15953872-7690781, http://linkedlifedata.com/resource/pubmed/commentcorrection/15953872-8055205, http://linkedlifedata.com/resource/pubmed/commentcorrection/15953872-8712877, http://linkedlifedata.com/resource/pubmed/commentcorrection/15953872-8940048, http://linkedlifedata.com/resource/pubmed/commentcorrection/15953872-9421490, http://linkedlifedata.com/resource/pubmed/commentcorrection/15953872-9566352, http://linkedlifedata.com/resource/pubmed/commentcorrection/15953872-9886436
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
1011-8934
pubmed:author
pubmed:issnType
Print
pubmed:volume
20
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
473-8
pubmed:dateRevised
2010-9-20
pubmed:meshHeading
pubmed:year
2005
pubmed:articleTitle
Diagnostic performances of anti-cyclic citrullinated peptides antibody and antifilaggrin antibody in Korean patients with rheumatoid arthritis.
pubmed:affiliation
Department of Laboratory Medicine, Eulji University, School of Medicine, Daejeon, Korea.
pubmed:publicationType
Journal Article, Comparative Study, Research Support, Non-U.S. Gov't